Virtus Investment Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-164
Closed -$90.3K 340
2022
Q4
$90.3K Hold
164
0.06% 280
2022
Q3
$83K Buy
+164
New +$91.8K 0.04% 313
2018
Q1
Sell
-20,988
Closed -$3.98M 394
2017
Q4
$3.98M Sell
20,988
-3,723
-15% -$713K 0.43% 68
2017
Q3
$4.68M Sell
24,711
-3,349
-12% -$607K 0.49% 58
2017
Q2
$4.9M Buy
28,060
+25,783
+1,132% +$4.33M 0.48% 61
2017
Q1
$350K Sell
2,277
-41,084
-95% -$6.28M 0.03% 356
2016
Q4
$6.12M Sell
43,361
-19,568
-31% -$2.88M 0.47% 61
2016
Q3
$10M Buy
+62,929
New +$9.7M 0.64% 35

Other funds holding TMO

Virtus Investment Advisers's TMO Position: Q1 2023 in Review

Virtus Investment Advisers sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 164 shares — an estimated $90.3K sold.

Virtus Investment Advisers first reported a position in TMO in Q3 2016 and held it in 8 quarters. The position peaked at $10M in Q3 2016. 2,387 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Virtus Investment Advisers reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Virtus Investment Advisers sold 164 Thermo Fisher Scientific shares in Q1 2023, an estimated $90.3K.
  • Virtus Investment Advisers first reported a position in Thermo Fisher Scientific in Q3 2016 and held it in 8 quarters.
  • Virtus Investment Advisers's Thermo Fisher Scientific position peaked at $10M in Q3 2016.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Virtus Investment Advisers's 13F filing for Q1 2023, filed 15 May 2023.